(Q73201224)
Statements
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma (English)
Stephen Y Chan
Alan N Gordon
Robert E Coleman
James B Hall
Mark S Berger
Matthew L Sherman
Catharine B Eten
26 February 2003